Business Context and Reporting Period
This Form 6-K filing by EUDA Health Holdings Ltd covers the month of April 2026. The report addresses a regulatory notice received from The Nasdaq Stock Market regarding the Company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a listing compliance issue rather than financial performance data.
Material Changes
On April 23, 2026, the Company received a notice from Nasdaq indicating a failure to maintain the Minimum Market Value of Listed Securities (MVLS) of $35 million over the preceding 32 consecutive business days, as required by Nasdaq Listing Rule 5550(b)(2).
Outlook, Risks, and Contingencies
- Compliance Period: The Company has been granted an 180-calendar-day period, ending October 20, 2026, to regain compliance.
- Compliance Requirement: To remain listed, the Market Value of Listed Securities must close at $35,000,000 or more for a minimum of ten consecutive business days during the compliance period.
- Delisting Risk: Failure to regain compliance by the deadline may result in a notice of delisting. While the Company may appeal such a determination, there is no assurance that compliance can be achieved or that an appeal would be successful.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities to assess proximity to the $35 million threshold.
- Monitor the Company's stock price performance over the next 180 days to determine if the 10-day consecutive closing requirement can be met.
- Review any future press releases or filings for updates on the Company's strategy to address the MVLS deficiency.
- Confirm whether the Company has filed an appeal if a delisting notice is issued after October 20, 2026.